Tag: options

Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 years

Key market opportunities in North America's online food delivery include rising demand for convenience, growth of healthy meal options, and enhanced delivery services. Dominated by mobile apps and online payments, the U.S. leads due to tech reliance and quick service expansion. Cloud kitchens also drive growth.

The Europe robotic lawn mower market offers opportunities driven by rising demand for time-saving, eco-friendly gardening solutions. Key growth areas include residential adoption, smart and simple technology options, and increasing sales via specialty stores, with Germany leading the market.

The North America instant noodles market is driven by the rising interest in Asian cuisine, demand for affordable meals, and busy lifestyles seeking convenience. Opportunities arise from e-commerce expansion, product innovation with healthier and premium options, and increased retail availability, appealing to diverse consumer preferences.

CINCINNATI, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today reported financial results for the second quarter ended June 30, 2025.

SAN DIEGO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC ID: RGBP and RGBPP) today provided further insight into its planned Phase 1 clinical trial of HemaXellerate, the company’s innovative stem cell-derived therapy, which has already received U.S. FDA clearance. While the initial focus is on treating aplastic anemia, a rare orphan indication, Regen BioPharma is evaluating expanded applications for this groundbreaking therapy in markets poised for significant growth.

SOUTH SAN FRANCISCO, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) --  Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to purchase an aggregate of 42,300 shares of the Company’s stock (the “Inducement Grant”) to newly hired employees on August 12, 2025 (the “Grant Date”), in connection with the commencement of employment.

MARKHAM, Ontario, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of August 2025, representing $0.936 per Common Share on an annualized basis.